Data gathered: February 8
Alternative Data for Century Therapeutics
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Sentiment | 84 | Sign up | Sign up | Sign up |
| Webpage traffic | 5,000 | Sign up | Sign up | Sign up |
| Google Trends | 19 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 427 | Sign up | Sign up | Sign up |
| Twitter Mentions | 6 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
About Century Therapeutics
None
| Price | $0.73 |
| Target Price | Sign up |
| Volume | 516,680 |
| Market Cap | $65M |
| Year Range | $0.73 - $3.35 |
| Dividend Yield | 0% |
| Analyst Rating | 80% buy |
| Industry | Biotechnology |
In the news
 |
Analysts Set Century Therapeutics, Inc. (NASDAQ:IPSC) PT at $10.00January 24 - ETF Daily News |
|
Century Therapeutics, Inc. (NASDAQ:IPSC) Shares Bought by Barclays PLCJanuary 24 - ETF Daily News |
Century Therapeutics Announces Investigator-Initiated Phase 1/2 Trial of its iPSC-derived iNK Cell Therapy CNTY-101 in B-cell Mediated Autoimmune Diseases Sponsored by Internationally Renowned Key Opinion LeadersJanuary 21 - GlobeNewswire |
|
|
Century Therapeutics, Inc. (NASDAQ:IPSC) Sees Significant Increase in Short InterestJanuary 19 - ETF Daily News |
|
Jane Street Group LLC Cuts Holdings in Century Therapeutics, Inc. (NASDAQ:IPSC)January 17 - ETF Daily News |
|
Barclays PLC Buys 45,797 Shares of Century Therapeutics, Inc. (NASDAQ:IPSC)January 9 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 790,000 | 8.4M | -7.6M | -31M | -35M | -0.370 |
| Q2 '24 | 770,000 | 8.3M | -7.5M | -31M | -32M | -0.380 |
| Q1 '24 | 860,000 | 8.7M | -7.9M | -28M | -28M | -0.450 |
| Q4 '23 | 270,000 | 21M | -20M | -39M | -27M | -0.650 |
| Q3 '23 | 150,000 | 9M | -8.8M | -33M | -28M | -0.550 |
Insider Transactions View All
| Carr Douglas filed to sell 316,796 shares at $0.8. February 5 '25 |
| Farid Adrienne filed to sell 134,076 shares at $0.8. February 5 '25 |
| Carr Douglas filed to sell 317,147 shares at $1.2. November 5 '24 |
| Farid Adrienne filed to sell 135,130 shares at $1.2. November 5 '24 |
| Quimi Daphne filed to buy 5,000 shares at $1.5. September 16 '24 |
Similar companies
Read more about Century Therapeutics (IPSC) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions, news mentions & customer reviews.
What is the Market Cap of Century Therapeutics?
The Market Cap of Century Therapeutics is $65M.
What is the current stock price of Century Therapeutics?
Currently, the price of one share of Century Therapeutics stock is $0.73.
How can I analyze the IPSC stock price chart for investment decisions?
The IPSC stock price chart above provides a comprehensive visual representation of Century Therapeutics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Century Therapeutics shares. Our platform offers an up-to-date IPSC stock price chart, along with technical data analysis and alternative data insights.
Does IPSC offer dividends to its shareholders?
As of our latest update, Century Therapeutics (IPSC) does not offer dividends to its shareholders. Investors interested in Century Therapeutics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Century Therapeutics?
Some of the similar stocks of Century Therapeutics are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.